Pharmacogenomics

Pharmacogenomics is the study of the genome in drug response.  It investigates the impact of acquired and inherited genetic variation on drug response in patients by connecting gene expression or single-nucleotide polymorphisms with pharmacokinetics and pharmacodynamics. There are several identified genes that are significantly responsible for differences in medication metabolism and response. For the sake of brevity, the focus of this article will concentrate on the genes that are more frequently recognised and used clinically. They are Cytochrome P450s, VKORC1, and TPMT. Patient genotypes are typically classified as Ultra-rapid metabolizer, Extensive metabolizer, Intermediate metabolizer, or Poor metabolizer. Pharmacogenomics could help to limit the occurrence of polypharmacy. It is hoped that with personalised medicinal therapies, patients will not need to take multiple medications to treat the same ailment. Toxicogenomics is a branch of pharmacology that deals with the collecting, interpretation, and preservation of information about gene and protein activity inside a specific cell or tissue of an organism in response to toxic chemical exposure.

    Related Conference of Pharmacogenomics

    October 23-24, 2025

    21st Annual Meet on Pharmaceutical Sciences

    Paris, France
    November 11-12, 2025

    6th Annual Congress on Antibiotics and Bacterial Infections

    Amsterdam, Netherlands
    November 13-14, 2025

    21st International Conference on Pharmaceutical Chemistry

    Aix-en-Provence, France
    November 20-21, 2025

    21st Annual Congress on Pharmacology and Toxicology

    Paris, France
    November 27-28, 2025

    4th World Conference on Pharma Industry and Medical Devices

    Zurich, Switzerland
    November 27-28, 2025

    4th World Congress on Precision and Personalized Medicine

    Zurich, Switzerland
    December 01-02, 2025

    13th International Conference on Clinical Trials

    Vancouver, Canada
    December 30-31, 2025

    40th World Congress on Pharmacology and Therapeutics

    Valencia, Spain
    February 23-24, 2026

    3rd World Congress on Biologics and Biosimilars

    London, UK
    March 23-24, 2026

    36th Annual European Pharma Congress

    London, UK
    April 16-17, 2026

    19th European Biosimilars Congress

    Rome, Italy
    April 27-28, 2026

    9th European Biopharma Congress

    Paris, Aland Islands
    May 28-29, 2026

    3rd International Conference on Pharmacognosy

    Madrid, Spain
    July 27-28, 2026

    39th World Congress on Pharmacology

    Rome, Italy

    Pharmacogenomics Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in